• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Gastroenterology

Metagenomics: A new method of identifying bacterial outbreaks

bys25qthea
April 10, 2013
in Gastroenterology, Infectious Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD/CDC

1. Culture-independent identification of outbreak pathogens using metagenomics allows for recognition of unusual organisms for which laboratory methods do not exist.

2. The challenges associated with the use of metagenomics include: low sensitivity, longer processing times, and cost.

Study Rundown: The rapid confirmation and characterization of pathogens in common infections are lacking, and antibiotic resistance is increasing at a disconcerting rate. Therefore, the identification of scientific methods that expedite the recognition of causative organisms is critical. In this study using samples from the 2011 Germany Shiga-toxin E. coli (STEC) outbreak, the use of metagenomics is demonstrated to be able to recover genomic DNA from outbreak samples and subsequently identify outbreak strains and antibiotic resistant genes. Ideally, with this information, it would be possible to pinpoint the causative organism and tailor medical treatment based upon the results. The pivotal advantage of metagenomics is that it allows for the recognition of unusual organisms for which laboratory methods do not exist.

Unfortunately, a relatively low sensitivity of 67% represents a major disadvantage of metagenomics in a diagnostic setting. While metagenomics is able to reconstruct a genomic sequence from a pool of DNA, it does not identify a particular organism as a pathogen, even with the identification of virulent genes. Also, while metagenomics is also capable of detecting antibiotic resistance genes, it cannot recognize the original species to which it belongs. Given such limitations, further investigation into the complex regulation of genes and cellular activities associated with infectivity is necessary before this technology can be used in a clinically implementable manner in identifying causative organisms in disease.

Click to read the study, published today in JAMA

Click to read an accompanying editorial in JAMA

RELATED REPORTS

The Scan by 2 Minute Medicine®: The Last Dance, Head of State, Trouble on the Farm and the Heart of COVID-19!

Oral microbiome therapy reduced Clostridioides difficile recurrence

Cholesterol-containing lipid particles protect mice from lethal bacterial toxins

In-Depth [retrospective study]: In this study, 45 fecal samples were collected from patients with diarrhea during the 2011 outbreak of Shiga-toxigenic Escherichia coli (STEC) O104:H4 in Germany. In phase 1, the fecal samples were subjected to metagenomics (open-ended sequencing without enrichment or amplification). The results were assembled into environmental gene tags (DNA sequences that contain genes that can be used to identify the organisms from which they arise). The EGTs were selected for EGTs present in at least 20 samples and those with matches to healthy human samples were subtracted. The remaining EGTs were subjected to taxonomic analysis and 65% were allocated to the Enterobacteriales. In phase 2, the alignment phase, outbreak-specific samples were referenced against the STEC outbreak strain. Sequences from the Shiga-toxin gene were detected in 27 out of 40 (67%) STEC-positive samples. The outbreak strain genome was isolated from 10 samples at >10-fold coverage and from 26 samples at >1-fold coverage.

By Brittany Hasty and Rif Rahman

More from this author: Sublingual immunotherapy may be safe and effective for asthma and allergic rhinoconjunctivitis, Sildenafil does not improve outcomes in patients with heart failure, Increased incidence of advanced breast cancer found in young women

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

 

Tags: ecolimetagenomicsShigatoxin
Previous Post

New gene variants linked with Alzheimer Disease in African Americans

Next Post

Science: tried and true? [Perspective]

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: The Last Dance, Head of State, Trouble on the Farm and the Heart of COVID-19!

November 1, 2022
[Physician Comment] The extent of C. difficile infections may not differ in light of immune status
Gastroenterology

Oral microbiome therapy reduced Clostridioides difficile recurrence

January 24, 2022
Home scoring system may prevent unnecessary pharyngitis clinic visits
Chronic Disease

Cholesterol-containing lipid particles protect mice from lethal bacterial toxins

November 7, 2014
Next Post
Science: tried and true? [Perspective]

Science: tried and true? [Perspective]

Functional MRI map for physical pain identified

Functional MRI map for physical pain identified

New chemotherapy precludes the need for radiotherapy in primary mediastinal B-cell lymphoma

New chemotherapy precludes the need for radiotherapy in primary mediastinal B-cell lymphoma

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Synergistic interaction between risk burden and genetics for atrial fibrillation development
  • Nivolumab plus ipilimumab does not improve survival in post-nephrectomy patients with renal cell carcinoma
  • Specific histopathologic renal lesions may be associated with increased risk of cardiovascular disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options